Category: Oncology/Hematology
Oncology/Hematology market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Bladder Cancer Therapeutics
The 2025-2030 World Outlook for Bladder Cancer Therapeutics This study covers the world outlook for bladder cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Multiple Myeloma Therapeutics
The 2025-2030 World Outlook for Multiple Myeloma Therapeutics This study covers the world outlook for multiple myeloma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Cervical Cancer Diagnostics
The 2025-2030 World Outlook for Cervical Cancer Diagnostics This study covers the world outlook for cervical cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Cervical Cancer Drugs and Diagnostics
The 2025-2030 World Outlook for Cervical Cancer Drugs and Diagnostics This study covers the world outlook for cervical cancer drugs and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Triple-Negative Breast Cancer Treatments
The 2025-2030 World Outlook for Triple-Negative Breast Cancer Treatments This study covers the world outlook for triple-negative breast cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Therapeutics
The 2025-2030 World Outlook for Colorectal Cancer Therapeutics This study covers the world outlook for colorectal cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Oncology Nutrition
The 2025-2030 World Outlook for Oncology Nutrition This study covers the world outlook for oncology nutrition across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Therapies and Diagnostics for Ovarian Cancers
The 2025-2030 World Outlook for Therapies and Diagnostics for Ovarian Cancers This study covers the world outlook for therapies and diagnostics for ovarian cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2025-2030 World Outlook for Cancer Therapies
The 2025-2030 World Outlook for Cancer Therapies This study covers the world outlook for cancer therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Cancer Tumor Profiling
The 2025-2030 World Outlook for Cancer Tumor Profiling This study covers the world outlook for cancer tumor profiling across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Neuroendocrine Carcinoma
The 2025-2030 World Outlook for Neuroendocrine Carcinoma This study covers the world outlook for neuroendocrine carcinoma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Immunotherapy Cancer Drugs
The 2025-2030 World Outlook for Immunotherapy Cancer Drugs This study covers the world outlook for immunotherapy cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Kidney Cancer Drugs
The 2025-2030 World Outlook for Kidney Cancer Drugs This study covers the world outlook for kidney cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Cancer Supportive Care Therapeutics
The 2025-2030 World Outlook for Cancer Supportive Care Therapeutics This study covers the world outlook for cancer supportive care therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Basal Cell Carcinoma Treatments
The 2025-2030 World Outlook for Basal Cell Carcinoma Treatments This study covers the world outlook for basal cell carcinoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Fecal Occult Blood Tests for In-Vitro Colorectal Cancer Screenings
The 2025-2030 World Outlook for Fecal Occult Blood Tests for In-Vitro Colorectal Cancer Screenings This study covers the world outlook for fecal occult blood tests for in-vitro colorectal cancer screenings across more than 190 countries. For each year reported, estimates are given for the latent dem ... Read More
-
The 2025-2030 World Outlook for Central Nervous System Lymphoma
The 2025-2030 World Outlook for Central Nervous System Lymphoma This study covers the world outlook for central nervous system lymphoma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Cervical Cancer Diagnostic Testing
The 2025-2030 World Outlook for Cervical Cancer Diagnostic Testing This study covers the world outlook for cervical cancer diagnostic testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Non-Hematological Cancer Treatments
The 2025-2030 World Outlook for Non-Hematological Cancer Treatments This study covers the world outlook for non-hematological cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma This study covers the world outlook for non-Hodgkin lymphoma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Oncology Therapeutics
The 2025-2030 World Outlook for Oncology Therapeutics This study covers the world outlook for oncology therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Treatments
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Treatments This study covers the world outlook for non-Hodgkin lymphoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Sarcoma Drugs
The 2025-2030 World Outlook for Sarcoma Drugs This study covers the world outlook for sarcoma drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More
-
The 2025-2030 World Outlook for Next Generation Cancer Diagnostics
The 2025-2030 World Outlook for Next Generation Cancer Diagnostics This study covers the world outlook for next generation cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Stomach and Gastric Cancer Treatments
The 2025-2030 World Outlook for Stomach and Gastric Cancer Treatments This study covers the world outlook for stomach and gastric cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
Research Assistance
